Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1164888/000149315222003537/form8-k.htm
May 2022
February 2022
November 2021
October 2021
September 2021
August 2021
August 2021
June 2021
April 2021
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1164888/000149315222003537/form8-k.htm
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Kyto Biopharma Inc.
Kyto Biopharma Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 8-K Corporate News
Ticker: KBPHEvents:
CIK: 1164888
Form Type: 8-K Corporate News
Accession Number: 0001493152-22-003537
Submitted to the SEC: Wed Feb 09 2022 8:48:47 AM EST
Accepted by the SEC: Wed Feb 09 2022
Period: Friday, February 4, 2022
Industry: Pharmaceutical Preparations